e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Diffuse parenchymal lung disease III
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of pirfenidone on chronic interstitial pneumonia
H. Takoi, Y. Miura, Y. Tsunoda, Y. Sumazaki, T. Tanaka, S. Y. Lin, Y. Yatagai, A. Sekine, K. Hayashihara, T. Saito (Ibaraki, Tokyo, Japan)
Source:
Annual Congress 2012 - Diffuse parenchymal lung disease III
Session:
Diffuse parenchymal lung disease III
Session type:
Thematic Poster Session
Number:
3653
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Takoi, Y. Miura, Y. Tsunoda, Y. Sumazaki, T. Tanaka, S. Y. Lin, Y. Yatagai, A. Sekine, K. Hayashihara, T. Saito (Ibaraki, Tokyo, Japan). Effect of pirfenidone on chronic interstitial pneumonia. Eur Respir J 2012; 40: Suppl. 56, 3653
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J, 50 (4) 1701157; 10.1183/13993003.01157-2017
Year: 2017
Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
Source: Eur Respir J 2005; 25: 528-533
Year: 2005
Cyclosporine A in the treatment of idiopathic pulmonary fibrosis/usual interstitial pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 62s
Year: 2002
Prognostic factors analysis of patients with acute exacerbation of idiopathic interstitial pneumonias treated by polymyxin B hemoperfusion
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia
Source: Eur Respir J 2002; 19: 1114-1118
Year: 2002
Usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Intravenous pulse doses of high-dose corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Causes of chronic cough in patients with interstitial pneumonia
Source: Annual Congress 2008 - Lung function, airways and cough
Year: 2008
Ciprofloxacin-induced acute interstitial pneumonitis
Source: Eur Respir J 2004; 23: 172-174
Year: 2004
Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids
Source: Breathe, 16 (3) 200086; 10.1183/20734735.0086-2020
Year: 2020
Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Source: Eur Respir Rev 2009; 18: 129-132
Year: 2009
Chronic hypersensitivity pneumonitis and its differential diagnosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=189
Year: 2007
Effect of baseline statin use on benefit of nintedanib
Source: International Congress 2016 – IPF treatment II
Year: 2016
The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008
Clinical significance of histological classification of idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 19: 275-283
Year: 2002
Acute exacerbations of progressive-fibrosing interstitial lung diseases
Source: Eur Respir Rev, 27 (150) 180071; 10.1183/16000617.0071-2018
Year: 2018
Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia
Source: Eur Respir J 2015; 45: 1624-1631
Year: 2015
Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015
Acute exacerbations of interstitial lung disease
Source: Eur Respir Monogr 2016; 74: 117-131
Year: 2016
Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept